October 2023 FDA Recall Drug by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
D-0153-2024 - Failed Content Uniformity Specifications

This Class I drug recall was voluntarily initiated by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories on October 23, 2023 for the product Drug. The FDA reported the reason for recall as failed content uniformity specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0153-2024

Reason for Recall
Failed Content Uniformity Specifications
Initiated
10-23-2023
Reported
12-27-2023
Quantity
3718 saleable units

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Nationwide in the USA
Phenytoin Oral Suspension, USP, 100 mg/4 mL, packaged in packaged in 4 mL unit dose cups (NDC 0904-7079-24), 50 per case (NDC 0904-7079-57), Rx only, Major Pharmaceuticals Livonia, MI 48152

Batch or Lot Expiration Information

Lot# C00099, C00115 Exp. date: 07/31/2024; C00079 Exp. date: 12/31/2023